Aclaris Therapeutics Inc (ACRS)

18.38 -1.27  -6.46% NASDAQ Jun 11, 20:00 USD

Aclaris Therapeutics Cash from Financing (TTM):

108.20M for March 31, 2021
View 4,000+ financial data types
View Full Chart

Cash from Financing (TTM) Chart

Export Data
Save Image
Print Image

Historical Cash from Financing (TTM) Data

View and export this data going back to 2015. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
March 31, 2021 108.20M
Dec. 31, 2020 18.37M
Sept. 30, 2020 -19.47M
June 30, 2020 -19.26M
March 31, 2020 -19.28M
Dec. 31, 2019 -30.32M
Sept. 30, 2019 127.88M
June 30, 2019 127.96M
March 31, 2019 127.78M
Dec. 31, 2018 128.26M
Sept. 30, 2018 0.00
June 30, 2018 80.90M
March 31, 2018 100.54M
Dec. 31, 2017 100.39M
Sept. 30, 2017 198.73M
June 30, 2017 117.82M
March 31, 2017 117.04M
Dec. 31, 2016
Sept. 30, 2016
June 30, 2016
March 31, 2016
Dec. 31, 2015 96.41M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.


Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Benchmarks

Ocugen Inc 57.42M
GBS Inc 23.60M
Precipio Inc 9.26M

Cash from Financing (TTM) Range, Past 5 Years

Minimum -30.32M Dec 2019
Maximum 198.73M Sep 2017
Average 74.44M


Top Biotech Stocks for Q3 2021
Yahoo 06/08 15:16 ET



Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.